Vincent Cheung is currently the CEO of Nan Fung Group - an international business conglomerate with global interests in real estates, life sciences and financial investments. Vincent is also Chairman of Nan Fung Life Sciences (NFLS), a global investment platform focusing on life sciences, and he co-founded the biotech VC fund Pivotal bioVenture Partners with investment teams in both US and China. Under his leadership, NFLS has built significant presence across the industry (including therapeutics, medical devices and diagnostics) and all development stages. His vision is to build NFLS to become the ideal partner for scientists, entrepreneurs, corporations and investors in the life sciences space.

Vincent has been a member of The National Committee of the Chinese People’s Political Consultation Conference for Shanghai City since 2012.

Vincent graduated with high honours in Molecular and Cell Biology from University of California, Berkeley. While in Berkeley, he worked in Lawrence Berkeley National Laboratory as an independent researcher.

Shannon Cheung joined Pivotal China in 2018. He is also the Chairman and Chief Executive Officer of Averest Capital, an investment company focusing on healthcare and TMT sectors, and Co-Founder and Vice Chairman of Likang Life Sciences. Shannon has participated in the investment of over 40 technology companies in China, including Alibaba Group, Hero Entertainment, VSPN, China Music Corporation (currently known as Tencent Music), CMGE, Yixin Group, Alltech Medical Systems, MChang, All Football, 91huayi.com (China’s largest online continuing education platform for doctors). Prior to Averest Capital, Shannon was Managing Director of global banking coverage in HSBC Markets (Asia) Limited and Chief Representative of HSBC (Securities Business) Beijing Representative Office, where he was responsible for business origination of investment banking in China, including IPOs and other equity related products, M&A advisory and high yield bond issuance.

Shannon is the Founder and President of Fin Society, a non-profit professional fraternity aiming to enhance the competitiveness of finance practitioners in Hong Kong and nurture next-generation finance industry leaders. He is also a recipient of the Medal of Honour from the Government of Hong Kong.

Shannon holds a Bachelor of Commerce degree with distinction from the University of Calgary.

Nancy Ip is the President of The Hong Kong University of Science and Technology (HKUST) and the Morningside Professor of Life Science. Taking office in October 2022, she is the first female president of a publicly funded university in Hong Kong.

Prof Ip received her PhD degree in Pharmacology from Harvard University, after which she held the position of Senior Staff Scientist at Regeneron Pharmaceuticals Inc. in New York. Since joining HKUST in 1993, she has held several key positions including Vice-President for Research and Development, Dean of Science, and Head of the Department of Biochemistry. 

Prof Ip is a world-renowned neuroscientist. Her major research interests are in understanding the complex mechanisms underlying proper brain functions, as well as drug target discovery for neurodegenerative diseases, particularly Alzheimer’s disease. Her outstanding research has resulted in 349 scientific papers, which have received over 52,306 SCI citations, and she holds 99 patents. She has been recognized in Stanford University's World Top 2% Scientist List, and ranks among the top 10 neuroscientists in China in the 2025 Best Scientists Rankings by Research.com.

Prof Ip’s professional achievements are internationally recognized by prestigious organizations. She has been elected to the Chinese Academy of Sciences, the U.S. National Academy of Sciences, the American Academy of Arts and Sciences, the World Academy of Sciences, and the Hong Kong Academy of Sciences. Additionally, she has received numerous awards and honors including the National Natural Science Awards, the L’OREAL-UNESCO for Women in Science Award, and being named one of the 10 Science Stars of China by Nature.

Antony Leung, former Financial Secretary of Hong Kong Special Administrative Region, is Group Chairman of Nan Fung Group, a leading regional conglomerate focusing on property, financial investment and investments in life sciences. He is also Group Chairman & Co-Founder of New Frontier Group, one of the leading privately owned health care businesses in China, and Chairman & Co-Founder of Solomon Learning Group, a Hong Kong-based social enterprise that promotes education of money and morals, as well as generative AI. Concurrently, Antony is the chairman of two charity organizations - Heifer Hong Kong and Food Angel as well as an Independent Non-Executive Director of China Construction Bank.

Antony also has extensive experience in financial services, including Chairman of Greater China of Blackstone, Chairman of Asia of JP Morgan Chase, Asia Head of Citi Private Bank, Regional Head of Citi Investment Bank, Treasury and Greater China. In addition, he was Independent Director of China Merchants Bank, Industrial and Commercial Bank of China, China Mobile (Hong Kong) Limited, American International Assurance (Hong Kong) Limited, International Advisory Board Member of China Development Bank and Chairman of Harvard Business School Association of Hong Kong. His past public service included Non-Official Member of the Executive Council, Chairman of Education Commission, Chairman of University Grants Committee, Member of Exchange Fund Advisory Committee, Director of Hong Kong Airport Authority and Hong Kong Futures Exchange, Member of the Preparatory Committee and Election Committee for the Hong Kong Special Administrative Region and Hong Kong Affairs Advisors.